Lynne M. Vickery‐Clark

Author

Also Known As

L M Vickery-Clark, L Vickery-Clark, L. M Vickery-Clark, L. VICKERY‐CLARK, L. Vickery-Clark, L.M. Vickery-Clark, Lynne M. Vickery-Clark, Lynne M. Vickery‐Clark, Lynne Vickery-Clark

Publications

783

Citations

H-Index

Concepts

All Affiliations

New Frontier

About

Lynne M. Vickery‐Clark is an author at New Frontier specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	505
2	Biochemistry	2	2	157
3	Immunology	2	2	26
4	Allergy	1	1	147
5	Cellular Physiology	1	1	147

Lynne M. Vickery‐Clark

Publications

769

Citations

H-Index

Page 1

	Year	Citations
A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB 209670. S A Douglas, Calvert Louden, Lynne M. Vickery‐Clark, Circulation Research Vascular DiseaseAngiogenesisCardiovascular DiseaseMedicineVascular Pharmacology	1994	199
Expression of Endothelin-1, Endothelin-3, Endothelin-Converting Enzyme-1, and Endothelin-A and Endothelin-B Receptor mRNA After Angioplasty-Induced Neointimal Formation in the Rat Xinkang Wang, Stephen A. Douglas, Calvert Louden, Circulation Research	1996	148
Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. Douglas W.P. Hay, Roseanna M. Muccitelli, Stephanie S. Tucker, PubMed Lung InflammationPharmacotherapyExperimental PharmacologyCellular PhysiologyHuman Airways	1987	147
Endothelin‐1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ‐123 Stephen A. Douglas, Lynne M. Vickery‐Clark, Eliot H. Ohlstein British Journal of Pharmacology Acute Lung InjuryLung InflammationPulmonary ArteryHypoxic VasoconstrictionBlood Vessels	1993	50
Selective ETA receptor antagonism with BQ-123 is insufficient to inhibit angioplasty induced neointima formation in the rat SD Douglas, Lynne M. Vickery‐Clark, Calvert Louden, Cardiovascular Research	1995	46
Pharmacologic profile of SK&F 104353: a novel, potent and selective peptidoleukotriene receptor antagonist in guinea pig and human airways. Douglas W.P. Hay, Roseanna M. Muccitelli, Stephanie S. Tucker, Journal of Pharmacology and Experimental Therapeutics	1987	38
Selective Estrogen Receptor Modulator Idoxifene Inhibits Smooth Muscle Cell Proliferation, Enhances Reendothelialization, and Inhibits Neointimal Formation In Vivo After Vascular Injury Tianli Yue, Lynne M. Vickery‐Clark, Calvert Louden, Circulation	2000	32
Functional evidence that balloon angioplasty results in transient nitric oxide synthase induction Stephen A. Douglas, Lynne M. Vickery‐Clark, Eliot H. Ohlstein European Journal of Pharmacology AngiogenesisSynthase InductionCardiovascular DiseaseAtherosclerosisVascular Adaptation	1994	25
Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist Nambi Aiyar, Elayne Baker, Lynne M. Vickery‐Clark, European Journal of Pharmacology Molecular PharmacologyMedicineMechanism Of ActionPharmacological AgentVascular Biology	1995	20
The bronchopulmonary pharmacology of SK&F 104353 in anesthetized guinea pigs: demonstration of potent and selective antagonism of responses to peptidoleukotrienes. T J Torphy, John F. Newton, Martin A. Wasserman, PubMed AsthmaInflammatory Lung DiseaseLung InflammationReceptor AntagonistAnesthetized Guinea Pigs	1989	16

Page 1